PMID- 36421565 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221126 IS - 2310-2861 (Electronic) IS - 2310-2861 (Linking) VI - 8 IP - 11 DP - 2022 Nov 16 TI - Influence of Copper-Strontium Co-Doping on Bioactivity, Cytotoxicity and Antibacterial Activity of Mesoporous Bioactive Glass. LID - 10.3390/gels8110743 [doi] LID - 743 AB - Mesoporous bioactive glass (MBG) is an extensively studied biomaterial used for the healing of bone defects. Its biological applications can be tailored by introducing metallic ions, such as strontium (Sr) and copper (Cu), which can enhance its functionalities, including osteogenetic, angiogenetic and antibacterial functionalities. In this study, Cu and Sr ions were co-doped (ratio 1:1) with x = 0.5, 1 and 2 mol% each in glass with an intended nominal composition of 80SiO(2)-(15-2x)CaO-5P(2)O(5)-xCuO-xSrO and synthesized with an evaporation-induced self-assembly (EISA)-based sol-gel technique. XRD confirmed the amorphous nature of the glass, while compositional analysis using ICP-OES confirmed the presence of dopant ions with the required amounts. A TEM study of the MBG powders showed fringes that corresponded to the formation of a highly ordered mesoporous structure. The Cu-Sr-doped MBG showed a positive effect on apatite formation when immersed in SBF, although the release of Cu and Sr ions was relatively slow for 1 mol% of each co-dopant, which signified a stable network structure in the glass. The impact of the Cu and Sr ions on the osteoblast-like cell line MG-63 was assessed. At the particle concentrations of 1 wt./vol.% or lower, the cell viability was above 50%. An antibacterial test was conducted against Gram-negative E. coli and Gram-positive S. aureus bacteria. With a sequential increase in the co-doped ion content in the glass, the zone of inhibition for bacteria increased. The results suggest that the doping of MBG with Cu and Sr ions at up to 2 mol% can result in tailored sustained release of ions to enhance the applicability of the studied glass as a functional biomaterial for bone regeneration applications. FAU - Anand, Akrity AU - Anand A AD - Centre for Functional and Surface Functionalized Glass, Alexander Dubcek University of Trencin, 911 50 Trencin, Slovakia. AD - Institute of Biomaterials, University of Erlangen-Nuremberg, 91058 Erlangen, Germany. FAU - Sengupta, Susanta AU - Sengupta S AD - Centre for Functional and Surface Functionalized Glass, Alexander Dubcek University of Trencin, 911 50 Trencin, Slovakia. AD - Institute of Biomaterials, University of Erlangen-Nuremberg, 91058 Erlangen, Germany. FAU - Kankova, Hana AU - Kankova H AUID- ORCID: 0000-0001-5494-9754 AD - Centre for Functional and Surface Functionalized Glass, Alexander Dubcek University of Trencin, 911 50 Trencin, Slovakia. FAU - Svancarkova, Anna AU - Svancarkova A AD - Centre for Functional and Surface Functionalized Glass, Alexander Dubcek University of Trencin, 911 50 Trencin, Slovakia. FAU - Beltran, Ana M AU - Beltran AM AUID- ORCID: 0000-0003-2599-5908 AD - Departamento de Ingenieria y Ciencia de los Materiales y del Transporte, Escuela Politecnica Superior, Universidad de Sevilla, 41011 Seville, Spain. FAU - Galusek, Dusan AU - Galusek D AUID- ORCID: 0000-0001-5995-8780 AD - Centre for Functional and Surface Functionalized Glass, Alexander Dubcek University of Trencin, 911 50 Trencin, Slovakia. FAU - Boccaccini, Aldo R AU - Boccaccini AR AUID- ORCID: 0000-0002-7377-2955 AD - Institute of Biomaterials, University of Erlangen-Nuremberg, 91058 Erlangen, Germany. FAU - Galuskova, Dagmar AU - Galuskova D AUID- ORCID: 0000-0003-4114-1048 AD - Centre for Functional and Surface Functionalized Glass, Alexander Dubcek University of Trencin, 911 50 Trencin, Slovakia. LA - eng GR - 739566 and VEGA 1/0191/20/European Union's Horizon 2020 research and innovation program/ PT - Journal Article DEP - 20221116 PL - Switzerland TA - Gels JT - Gels (Basel, Switzerland) JID - 101696925 PMC - PMC9689600 OTO - NOTNLM OT - antibacterial activity OT - bioactivity OT - co-doping OT - cytotoxicity OT - mesoporous glass COIS- The authors declare no conflict of interest. EDAT- 2022/11/25 06:00 MHDA- 2022/11/25 06:01 PMCR- 2022/11/16 CRDT- 2022/11/24 09:56 PHST- 2022/08/27 00:00 [received] PHST- 2022/11/01 00:00 [revised] PHST- 2022/11/04 00:00 [accepted] PHST- 2022/11/24 09:56 [entrez] PHST- 2022/11/25 06:00 [pubmed] PHST- 2022/11/25 06:01 [medline] PHST- 2022/11/16 00:00 [pmc-release] AID - gels8110743 [pii] AID - gels-08-00743 [pii] AID - 10.3390/gels8110743 [doi] PST - epublish SO - Gels. 2022 Nov 16;8(11):743. doi: 10.3390/gels8110743.